PATENT CLAIM ANALYSIS

Application Number: 16175311
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "450000"]

Abstract:
Disclosed are particles for delivering cytokinese, such as IL-12, for the treatment of cancer. The particles comprise cytokines non-covalently bound to liposomes, where the liposomes are coated with polyelectrolytes.

Claim (Index 5):
The particle of  claim 3 , wherein the metal ion is selected from the group consisting of Fe(III), Co(II), Ni(II), Cu(II), and Zn(II).

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.30769
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15501028', '15433934', '15518665', '15340238', '14358705']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6665560575380225
- 35 USC 102 Novelty (BERT): 0.526656627818808
- Combined Prediction Score: 0.652566114566101
- Mean Citation Score: 180.371654
- Max Citation Score: 194.3446
- Similarity Product: 108.82948972725868

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test